11. Increased iron stores prolong the QT interval – a general population study including 20 261 individuals and meta‐analysis of thalassaemia major. (8th April 2016) Authors: Henriksen, Lise Fischer; Petri, Anne‐Sofie; Hasselbalch, Hans Carl; Kanters, Jørgen Kim; Ellervik, Christina Journal: British journal of haematology Issue: Volume 174:Number 5(2016) Page Start: 776 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Increased oxidative stress with substantial dysregulation of genes related to oxidative stress and DNA repair after laparoscopic colon cancer surgery. (December 2020) Authors: Watt, Sara Kehlet; Hasselbalch, Hans Carl; Skov, Vibe; Kjær, Lasse; Thomassen, Mads; Kruse, Torben A.; Burton, Mark; Poulsen, Henrik Enghusen; Gögenur, Ismail Journal: Surgical oncology Issue: Volume 35(2020) Page Start: 71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis. Issue 1 (February 2013) Authors: Silver, Richard T; Kiladjian, Jean-Jacques; Hasselbalch, Hans Carl Journal: Expert review of hematology Issue: Volume 6:Issue 1(2013) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis. Issue 1 (February 2013) Authors: Silver, Richard T; Kiladjian, Jean-Jacques; Hasselbalch, Hans Carl Journal: Expert review of hematology Issue: Volume 6:Issue 1(2013) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Interferon in polycythemia vera and related neoplasms. Can it become the treatment of choice without a randomized trial?. Issue 4 (August 2015) Authors: Hasselbalch, Hans Carl; Silver, Richard T Journal: Expert review of hematology Issue: Volume 8:Issue 4(2015) Page Start: 439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Loss-of-function polymorphism in IL6R reduces risk of JAK2V617F somatic mutation and myeloproliferative neoplasm: A Mendelian randomization study. (April 2020) Authors: Pedersen, Kasper Mønsted; Çolak, Yunus; Ellervik, Christina; Hasselbalch, Hans Carl; Bojesen, Stig Egil; Nordestgaard, Børge Grønne Journal: EClinicalMedicine Issue: Volume 21(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Minimal residual disease after long-term interferon-alpha2 treatment: a report on hematological, molecular and histomorphological response patterns in 10 patients with essential thrombocythemia and polycythemia vera. Issue 2 (1st February 2016) Authors: Utke Rank, Cecilie; Weis Bjerrum, Ole; Larsen, Thomas Stauffer; Kjær, Lasse; de Stricker, Karin; Riley, Caroline Hasselbalch; Hasselbalch, Hans Carl Journal: Leukemia & lymphoma Issue: Volume 57:Issue 2(2016:Feb.) Page Start: 348 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Minimal residual disease or cure in MPNs? Rationales and perspectives on combination therapy with interferon-alpha2 and ruxolitinib. Issue 5 (4th May 2017) Authors: Bjørn, Mads Emil; Hasselbalch, Hans Carl Journal: Expert review of hematology Issue: Volume 10:Issue 5(2017) Page Start: 393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Molecular profiling as a novel tool to predict response to interferon‐α2 in MPNs: The proof of concept in early myelofibrosis. Issue 14 (18th May 2017) Authors: Hasselbalch, Hans Carl Journal: Cancer Issue: Volume 123:Issue 14(2017) Page Start: 2600 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. MPNs as Inflammatory Diseases: The Evidence, Consequences, and Perspectives. (28th October 2015) Authors: Hasselbalch, Hans Carl; Bjørn, Mads Emil Other Names: Cooper Dianne Academic Editor. Journal: Mediators of inflammation Issue: Volume 2015(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗